Skip to content
value.today

Intercept Pharmaceuticals vs Moderna, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Moderna, Inc. is the larger company by market value: $90.1 B against $447 M for Intercept Pharmaceuticals, 202 times as much (market caps of Jul 30, 2023 for Intercept Pharmaceuticals and Oct 30, 2026 for Moderna, Inc.). Intercept Pharmaceuticals's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.
  • Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $286 M for Intercept Pharmaceuticals in the year to December 2022.
  • Intercept Pharmaceuticals made a net profit of $222 M, while Moderna, Inc. made a net loss of $2.8 B.
  • Intercept Pharmaceuticals keeps more of each dollar of sales: a net margin of 77.6% against -145.2% for Moderna, Inc.
  • Moderna, Inc. employs more people: 4,700 against 437 at Intercept Pharmaceuticals. Each employee brings in about $653,799 of revenue at Intercept Pharmaceuticals and $413,617 at Moderna, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0342685102713702020202120222023202420252026Intercept Pharmaceuticals 11Moderna, Inc. 1370

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$5B$10B$14B$19B20152016201720182019202020212022202320242025Intercept Pharmaceuticals $0BModerna, Inc. $2B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureIntercept Pharmaceuticals
ICPT
Moderna, Inc.
MRNA · #274 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded20022010
Size
Market cap$447 M*$90.1 B
Revenue$286 M$1.9 B
Net income$222 M▲ best$-2.8 B
Employees4374,700
Valuation
Price to sales—35.7×
Price to book—10.4×
Free cash flow yield—-2.3%
Profitability
Gross margin—55.4%
Operating margin—-158.1%
Net margin—-145.2%
Return on equity—-28.9%
Growth
Revenue growth—-39.9%
Revenue growth, 3 years a year—-53.4%
Financial strength
Debt to equity—0.1×
Cash
Free cash flow margin—-106.2%
Shareholder returns
Shareholder yield—0.0%
Strength scores
Piotroski F-score—3 of 9
Altman Z-score zone—safe
Data as ofMarket cap Jul 2023Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Intercept Pharmaceuticals or Moderna, Inc.?

Moderna, Inc. is the larger company by market value: $90.1 B against $447 M for Intercept Pharmaceuticals, 202 times as much (market caps of Jul 30, 2023 for Intercept Pharmaceuticals and Oct 30, 2026 for Moderna, Inc.). Intercept Pharmaceuticals's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.

Which makes more money, Intercept Pharmaceuticals or Moderna, Inc.?

Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $286 M for Intercept Pharmaceuticals in the year to December 2022. Intercept Pharmaceuticals made a net profit of $222 M, while Moderna, Inc. made a net loss of $2.8 B.

Which is more profitable, Intercept Pharmaceuticals or Moderna, Inc.?

Intercept Pharmaceuticals keeps more of each dollar of sales: a net margin of 77.6% against -145.2% for Moderna, Inc.

Which has more employees, Intercept Pharmaceuticals or Moderna, Inc.?

Moderna, Inc. employs more people: 4,700 against 437 at Intercept Pharmaceuticals. Each employee brings in about $653,799 of revenue at Intercept Pharmaceuticals and $413,617 at Moderna, Inc.